Why Partner with Furiex?
Furiex is a new and innovative drug development resource that the biopharmaceutical industry needs. In an increasingly competitive industry, pharmaceutical and biotechnology companies are seeking new, strategic approaches to feed pipelines by improving productivity and speed of drug development.
Furiex offers a unique partnering approach: We strategically plan development programs that quickly advance and deliver derisked drug candidates to our partners while sharing the financial risk of clinical development with them. Our approach brings financial strength, operational expertise and a proven track record in working with partners to reduce timelines and accelerate development.
Our Drug Development Expertise
At Furiex, we believe our people and their expertise are our greatest assets. We are dedicated to innovative drug design and scientific excellence. Eighty-five percent of our highly trained experts hold advanced degrees and our leadership team collectively has more than 75 years of drug development experience. We leverage this expertise to design unique development programs that address critical safety and efficacy questions with shorter timelines without sacrificing scientific integrity and quality.
Our core team has successfully delivered two Phase III ready compounds, Priligy® and Nesina®, to our partners, and both are now on the market. Not only do we have breadth of expertise, but also a strong passion and desire to bring life-improving therapies to patients by accelerating the product development efforts of our partners.
A New Approach
Our goal is to establish mutually beneficial drug development risk-sharing partnerships in which the innovator preserves more value while we optimize our potential for long-term growth. Furiex applies its expertise to drive programs to the next stage of development by designing, implementing and funding drug candidates of our partners in exchange for downstream rewards. We understand that each drug candidate and partner is unique so our deal structures are flexible and our deal terms are tailored to each partner and development program.
